The American company Johnson & Johnson has decided to postpone the use of its COVID-19 vaccine in Europe. She stated that she was aware of cases of thrombosis after vaccination.
In the text of the statement of the American company Johnson & Johnson it is said: “In addition, we are considering these cases together with the European authorities in the field of health care.”
Earlier, American regulators talked about intent to ban the use of the coronavirus vaccine by an American company due to the formation of blood clots in those who received the vaccine. The Food and Drug Administration (FDA) reported that after over 6.8 million doses of the drug were administered to US residents, 6 cases of severe thrombosis were recorded.
In early April, The New York Times reported that 15 million doses of the drug were lost by employees at Johnson & Johnson’s Baltimore plant due to a mistake in mixing vaccine ingredients. The FDA is reviewing the plant.